Skip to content
Screener

Net margin at other companies

Amgen logo
AmgenAMGN
23%+4.0pp
Regeneron Pharmaceuticals logo
Regeneron PharmaceuticalsREGN
27.9%-3.5pp
Aclaris Therapeutics logo
Aclaris TherapeuticsACRS
-921.5%+161pp
Shattuck Labs, Inc. logo
Shattuck Labs, Inc.STTK
-5,256.8%-14,625pp
AnaptysBio, Inc. logo
AnaptysBio, Inc.ANAB
-49.9%-22.6pp
Avalo Therapeutics logo
Avalo TherapeuticsAVTX
-7,965.8%-10,750pp

Other financials

Income statement

See full
Revenue$773.0K-17.5%
Operating income-$42.4M+4.5%
Net income-$39.7M+0.7%
EPS (diluted)-$0.73+1.4%

Balance sheet

See full
Cash & equivalents$79.4M+74.7%
Total debt$954.0K-38.9%
Total equity$271.0M-33.7%
Total assets$281.2M-33.1%

Cash flow

See full
Operating cash flow-$35.6M+9.2%
CapEx$54.0K-70.8%
Free cash flow-$30.7M-55.0%

Valuation

See full
Market cap$394.54M-54.7%
Enterprise value$316.1M-61.6%
P/S124.9×-195×

Profitability

See full
Operating margin-5,382.6%+1,393pp

Returns & leverage

See full
Return on equity-46%
Debt / equity0.0×
Current ratio28×-10.3×

Where this comes from

Calculated from Upstream Bio, Inc.’s reported figures.

Based on trailing twelve months.

The source filing: Upstream Bio, Inc.’s 10-Q, filed August 11, 2026. Open the filing →

Filed
Aug 11, 2026, 7:10 AM EDT
Fiscal quarter
Q2 FY2026
Calendar quarter
Q2 2026
Accession
0001193125-26-343417

FAQ

What is Upstream Bio, Inc.'s net margin?
Upstream Bio, Inc. (UPB) reported net margin of -4,955.7% in Q2 2026.
How has Upstream Bio, Inc.'s net margin changed year-over-year?
Upstream Bio, Inc.'s net margin decreased by 29.2% year-over-year, from -3,836.6% to -4,955.7%.
What does net margin mean?
Net income as a percentage of revenue (trailing twelve months). The bottom-line profitability measure after all costs, interest, and taxes.

Ask your AI about Upstream Bio, Inc.'s net margin.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude